Search

everythinglearnresearchcommunity

for

Search:↓

The ginseng cicada decoction effectively reduces atopic dermatitis symptoms and improves quality of life safely.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Low fucosylation boosts stem cell growth in the eye.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

High-dose ciclosporin significantly improved a young cat's severe skin condition.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

The new gel for hair loss is safe, effective, and reduces side effects.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

The hydrogel with neem and tridax extracts effectively treats seborrheic dermatitis.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Baricitinib is effective and safe for treating alopecia areata in Korea.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.